BioLineRx Stock Target Price and Analyst Consensus

BLRX Stock  USD 0.29  0.01  3.57%   
The current analyst and expert consensus on BioLineRx is Strong Buy, with only one strong buy opinion. The current projected BioLineRx target price consensus is 14.00 with 2 analyst opinions. Check out Macroaxis Advice on BioLineRx to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon.
For more information on how to buy BioLineRx Stock please use our How to Invest in BioLineRx guide.
The most common way BioLineRx analysts use to provide recommendation to the public is financial statements analysis. Many experts also interview BioLineRx executives and customers to further validate their buy or sell advice. Please note, the number of analysts providing the opinion is not sufficient to provide adequate consensus on BioLineRx. We encourage you to use your own analysis of BioLineRx to validate this buy or sell advice. BioLineRx buy-or-sell recommendation module provides average expert sentiment on the projected BioLineRx target price to derive its highest and lowest estimates based on projected price volatility of 6.9857.
Lowest Forecast
12.74
Highest Forecast
15.54
Target Price
14
Gross Profit is likely to drop to about 1.1 M in 2024. Pretax Profit Margin is likely to rise to -13.8 in 2024. At this time, BioLineRx's Current Deferred Revenue is fairly stable compared to the past year. Net Debt is likely to rise to about 7.7 M in 2024, whereas Total Assets are likely to drop slightly above 53.7 M in 2024.
  
It's important to approach BioLineRx's target price projections with caution. While they can be useful as part of a broader investment strategy, they are inherently speculative and subject to various kinds of risk, including market volatility and unforeseen external factors. Always consider multiple aspects and do your own research when making investment decisions.
Analysts determine stock price targets through various methods, including financial modeling, peer comparison, and company analysis. The stock price target is the analyst's best estimate of the future price of a stock and is used by investors to make investment decisions. However, it is important to note that stock price targets are not guaranteed, and the actual price of a stock can differ significantly from the target due to various factors such as market conditions, economic events, and company developments.

Steps to utilize BioLineRx price targets

BioLineRx's stock target price is an estimate of its future price, usually made by analysts. Using BioLineRx's target price to determine if it is a suitable investment can be done through the following steps:
  • Look at BioLineRx's target prices provided by various analysts and compare them. This can help you gain a more balanced view of the Stock's potential.
  • Look at the analyst's track record to determine if they have a history of accurately predicting stock prices.
  • Look at the Company's financials, including revenue, earnings, and debt, to determine if it is in good financial health.
  • Consider market conditions. For example, take into account the state of the economy, competition, and regulatory environment, to determine if BioLineRx's stock is likely to perform well.
  • Diversify your portfolio and do not rely solely on stock target prices to make investment decisions. Invest in a mix of stocks, bonds, and other assets to manage risk.
Remember that stock target prices are just estimates and are subject to change. Therefore, using them as one factor in a larger investment strategy is essential rather than relying solely on them to make decisions.

Additional BioLineRx Value Projection Modules

Most investment researchers agree that the mispricing and readjustment of any Stock value happens often and is sometimes even predictable, but there is no strong theory explaining why it happens. The current price of BioLineRx is a key component of BioLineRx valuation and have some predictive power on the future returns of a BioLineRx.
Hype
Prediction
LowEstimatedHigh
0.010.297.23
Details
Intrinsic
Valuation
LowRealHigh
0.010.287.22
Details
Naive
Forecast
LowNextHigh
00.177.11
Details
Earnings
Estimates (0)
LowProjected EPSHigh
-0.02-0.02-0.02
Details

Trending Themes

If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment.
Macroaxis Index Idea
Macroaxis Index
Invested few shares
Investor Favorites Idea
Investor Favorites
Invested few shares
Social Domain Idea
Social Domain
Invested few shares
SRI Sustainable Growth Idea
SRI Sustainable Growth
Invested few shares
Dividend Beast Idea
Dividend Beast
Invested over 50 shares
Macroaxis Picks Idea
Macroaxis Picks
Invested over 60 shares
Business Services Idea
Business Services
Invested few shares
Power Assets Idea
Power Assets
Invested over 200 shares
Artificial Intelligence Idea
Artificial Intelligence
Invested few shares

Additional Tools for BioLineRx Stock Analysis

When running BioLineRx's price analysis, check to measure BioLineRx's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BioLineRx is operating at the current time. Most of BioLineRx's value examination focuses on studying past and present price action to predict the probability of BioLineRx's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BioLineRx's price. Additionally, you may evaluate how the addition of BioLineRx to your portfolios can decrease your overall portfolio volatility.